Seen & Heard
In a new video series on Eyetube, host I. Paul Singh, MD, sits down with a range of guests to discuss new medical and pharmaceutical developments for the management of glaucoma. Topics covered include challenges in patient adherence, varying mechanisms of action, advances in drug delivery, and more.
“Be progressive in your technology and skills, and be old-fashioned in the people part of your business. Patients want to know how much you care before they care how much you know. And practices that understand this and implement it the best will be the most successful. Not only will it increase you and your team’s joy and job satisfaction, but the patients you touch will tell the world.”
—Vance Thompson, MD, FACS
Cataract & Refractive Surgery Today
The TM Up Close
Researchers at Indiana University used adaptive optics gonioscopy to image the trabecular meshwork in nine study participants, including two with pigment dispersion syndrome. They found that the technology allowed near cellular level resolution of the trabecular meshwork in vivo. (Image reprinted with permission from Translational Vision Science & Technology1)
1. King BJ, Burns SA, Sapoznik KA, Luo T, Gast TJ. High-resolution, adaptive optics imaging of the human trabecular meshwork in vivo. Transl Vis Sci Technol. 2019;8(5):5.
Social media can be a powerful tool for disseminating information to a wide network of users. Numerous accounts used January—Glaucoma Awareness Month—as an opportunity to spread the word about glaucoma. (Images: @zyloware, @drjenineesmail, @vspvisioncare)